| abstract |
The present invention comprises a cholesteryl ester transfer protein inhibitor of formula (I), a prodrug thereof, or a pharmaceutically acceptable salt of said compound or said prodrug, a pharmaceutical composition containing said deterrent, and a high density lipoprotein-cholesterol Diseases that are affected by low levels of HDL cholesterol and / or high levels of LDL-cholesterol and triglycerides by increasing certain plasma lipid levels and by lowering certain other plasma lipid levels such as LDL-cholesterol and triglycerides, eg For example, the present invention relates to the use of said inhibitor for treating atherosclerosis and cardiovascular disease in some mammals, including humans.n n n Formula I |